176 related articles for article (PubMed ID: 35223498)
1. Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study.
Tang D; Chen Y; Shi Y; Tao H; Tao S; Zhang Q; Ding B; He Z; Yu L; Wang C
Front Oncol; 2022; 12():817043. PubMed ID: 35223498
[TBL] [Abstract][Full Text] [Related]
2. Incidence, Prognostic Factors and Survival Outcome in Patients With Primary Hepatic Lymphoma.
Zhang SL; Chen C; Rao QW; Guo Z; Wang X; Wang ZM; Wang LS
Front Oncol; 2020; 10():750. PubMed ID: 32477954
[No Abstract] [Full Text] [Related]
3. Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study.
Hang H; Zhou H; Ma L
Medicine (Baltimore); 2024 Feb; 103(8):e37238. PubMed ID: 38394535
[TBL] [Abstract][Full Text] [Related]
4. Investigation of epidemiological characteristics and development of a nomogram to predict survival in primary ocular adnexal lymphoma.
Peng F; Su W; Zhang A; Huo B; Song T; Wei Z; Geng Z; Wang L
Clin Exp Ophthalmol; 2022 Aug; 50(6):615-631. PubMed ID: 35656846
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological features for primary lymphoma of the female genital tract patients and development of a nomogram to predict survival.
Peng F; Li J; Mu S; Qin Y; Ma J; Ai L; Hu Y
Ann Med; 2022 Dec; 54(1):962-976. PubMed ID: 35416104
[TBL] [Abstract][Full Text] [Related]
6. Nomograms for predicting cancer-specific survival in patients with primary central nervous system lymphoma: a population-based analysis.
Yang C; Ren X; Cui Y; Jiang H; Yu K; Li M; Zhao X; Zhu Q; Lin S
Ann Transl Med; 2021 Jul; 9(13):1055. PubMed ID: 34422967
[TBL] [Abstract][Full Text] [Related]
7. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
8. Comparison of the Effect of Chemoradiotherapy and Chemotherapy on the Survival of Patients with Primary Diffuse Large B-Cell Lymphoma of the Spine: A SEER-Based Study.
Cao S; Fan B; Sun Q; Chen J; Song X; Yin W
World Neurosurg; 2023 Jul; 175():e940-e949. PubMed ID: 37075894
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and survival outcome of primary pulmonary acinar cell carcinoma.
Meng FJ; Sun ZN; Wang ZN; Ma HM; Zhang WC; Gao ZY; Ji LL; Feng FK; Yang B; Wang CY; Chen ZY; Zhang N; Wang GS
Thorac Cancer; 2021 Sep; 12(18):2439-2448. PubMed ID: 34337871
[TBL] [Abstract][Full Text] [Related]
10. Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis.
Wang JQ; Deng RX; Liu H; Luo Y; Lu MM; Yang ZC
Front Oncol; 2022; 12():754967. PubMed ID: 35847870
[TBL] [Abstract][Full Text] [Related]
11. [Clinical Characteristics and Prognostic Factors of Patients with Primary Parotid Gland Lymphoma].
Xu P; Liu J; Chen HJ; Shang LM; Yan F; Xie XB; Gu WY; Lin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1077-1084. PubMed ID: 37551480
[TBL] [Abstract][Full Text] [Related]
12. Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study.
Wang M; Ma S; Shi W; Zhang Y; Luo S; Hu Y
Cancer Med; 2021 May; 10(10):3474-3485. PubMed ID: 33931950
[TBL] [Abstract][Full Text] [Related]
13. Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma.
Zhang G; Wu Y; Zhang J; Fang Z; Liu Z; Xu Z; Fan Y
Onco Targets Ther; 2018; 11():5535-5544. PubMed ID: 30233214
[TBL] [Abstract][Full Text] [Related]
14. Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma.
Yan Q; Zheng WJ; Chen QL; Wang BQ; Luo HY; Xue J; Wang XW
Medicine (Baltimore); 2019 Oct; 98(40):e17332. PubMed ID: 31577727
[TBL] [Abstract][Full Text] [Related]
15. Prognostic model and treatment choices for patients with primary intracranial central nervous system lymphoma: A population-based study.
Jiang Q; Zhan G; Jiang W; Xu Y; Zheng G; Jiang C; Lin D; Wang K; Zhu H
Clin Neurol Neurosurg; 2023 Oct; 233():107912. PubMed ID: 37531751
[TBL] [Abstract][Full Text] [Related]
16. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
Wang B; Chen LJ; Wang XY
Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for primary diff use large B-cell lymphoma of the brain.
Zhou Z; Chen J
Asian J Surg; 2023 Oct; 46(10):4357-4362. PubMed ID: 36535876
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.
Wang J; Zhou M; Zhou R; Xu J; Chen B
Front Oncol; 2020; 10():1093. PubMed ID: 32719748
[No Abstract] [Full Text] [Related]
19. Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.
Chihara D; Fowler NH; Oki Y; Fanale MA; Nastoupil LJ; Westin JR; Fayad LE; Neelapu SS; Cheah CY
Oncotarget; 2018 Jun; 9(48):28897-28902. PubMed ID: 29988979
[TBL] [Abstract][Full Text] [Related]
20. A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.
Guo Q; Wang Y; An J; Wang S; Dong X; Zhao H
Technol Cancer Res Treat; 2021; 20():15330338211027912. PubMed ID: 34190015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
